Exploring Three High Growth Tech Stocks In Australia [Yahoo! Finance]
Mesoblast Limited - American Depositary Shares (MESO)
US:NASDAQ Investor Relations:
investorsmedia.mesoblast.com
Company Research
Source: Yahoo! Finance
Top 10 High Growth Tech Companies In Australia Clinuvel Pharmaceuticals ?????? Pureprofile ?????? Adherium ?????? ImExHS ?????? Telix Pharmaceuticals ?????? AVA Risk Group ?????? Pointerra ?????? Wrkr ?????? Adveritas ?????? SiteMinder ?????? Let's dive into some prime choices out of from the screener. Simply Wall St Growth Rating: ?????? Overview: Mesoblast Limited is a biotechnology company focused on developing regenerative medicine products across Australia, the United States, Singapore, and Switzerland, with a market capitalization of A$1.70 billion. Operations: Mesoblast generates revenue primarily from the development of its cell technology platform for commercialization, amounting to $5.90 million. The company's focus is on advancing regenerative medicine products across multiple regions. Despite recent setbacks, including being dropped from the S&P/ASX Emerging Companies Index, Mesoblast Limited shows promise with a significa
Show less
Read more
Impact Snapshot
Event Time:
MESO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MESO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MESO alerts
High impacting Mesoblast Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
MESO
News
- Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings [Yahoo! Finance]Yahoo! Finance
- Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation MeetingsGlobeNewswire
- Mesoblast Limited (NASDAQ: MESO) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $24.00 price target on the stock, up previously from $15.00.MarketBeat
- Mesoblast Limited (NASDAQ: MESO) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.MarketBeat
- Ryoncil® Commercial Launch Update and Product PipelineGlobeNewswire